A phase I/II study of neoadjuvant chemoradiotherapy for pancreatic cancer. - J-PACS 05

The Jikei University school of medicine0 sites58 target enrollmentJanuary 31, 2021

Overview

No summary available.

Registry

who.int

Start Date

January 31, 2021

End Date

March 31, 2026

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

•1\) Exclude non\-curative factors found during radical resection 2\) Have overt pulmonary fibrosis or interstitial pneumonia 3\) Concomitant with active infectious diseases (HB, HCV, HIV infection, etc.) 4\) Have uncontrollable diabetes, heart failure, angina, arrhythmia and myocardial infarction within 6 months of onset 5\) Have watery diarrhea 6\) Cases using flucytosine and phenytoin 7\) Pregnant, lactating and likely or willing to become pregnant 8\) Have a serious drug allergy 9\) Have active double cancer (not applicable to cases 5 years after complete cure) 10\) Have other serious complications 11\) Have severe neuropsychiatric symptoms, renal impairment, hearing impairment 12\) Chickenpox patients 13\) Previous treatment history (surgical excision, chemotherapy, radiation, etc.) for this disease 14\) In addition, the doctor in charge judged that it was inappropriate to carry out this study safely.